Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 9/20 | 0.52 |
| ▸ | CA1 | P00915 | 8/20 | 0.52 |
| ▸ | CA9 | Q16790 | 7/20 | 0.52 |
| ▸ | CA6 | P23280 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | G6PD | P11413 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | CASP6 | P55212 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565103 | 0.86 | CDK2 (0.50) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL29545862 | 0.86 | CDK2 (0.50) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL3030721 | 0.84 | AURKA (0.53) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL9359459 | 0.83 | CDK2 (0.47) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL4458549 | 0.79 | CDK2 (0.44) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL5518503 | 0.79 | CDK2 (0.63) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL7761041 | 0.79 | CA2 (0.67) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL184251 | 0.78 | CDK2 (0.61) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL29965023 | 0.78 | CDK2 (0.61) | CDK2STAT3CA2CA1CA9 | |
| SCHEMBL564663 | 0.78 | HTR6 (0.58) | CDK2CA2CA1CA9CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5376151-A | Using iron complexes of azo dyes in place of chromium-based ones | NORTH CAROLINA STATE UNIVERSITY (US) | 1994-12-27 | — | — | US | claimed |
| CN-116721709-A | Method for detecting antibacterial activity of compound mixed sample | 浙江省水利河口研究院(浙江省海洋规划设计研究院) | 2023-09-08 | — | — | CN | disclosed |
| EP-2302000-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9051501-B2 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| EP-2100923-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-2088173-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-8008386-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| EP-2302000-A1 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20100063215-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100041810-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| WO-2010003970-A2 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-14 | — | — | WO | disclosed |
| WO-2010003970-A2 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-14 | — | — | WO | disclosed |
| US-20100000032-A1 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-07 | — | — | US | disclosed |
| US-20100000032-A1 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-07 | — | — | US | disclosed |
| US-20100000032-A1 | PHENOXAZINE DYES | Wetlands Incubator sprl (BE) | 2010-01-07 | — | — | US | disclosed |
| EP-2100923-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-2088173-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | Kaneka Corporation (JP) | 2009-08-12 | — | — | EP | disclosed |
| EP-0777703-A2 | DICYCLIC METAL COMPLEX FORMAZAN DERIVATIVES, PROCESS FOR PRODUCING THE SAME, COMPOSITION CONTAINING THE SAME AND DYEING PROCESS EMPLOYING THE SAME | Kyungin Synthetic Corporation (KR) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996033240-A2 | DICYCLIC METAL COMPLEX FORMAZAN DERIVATIVES, PROCESS FOR PRODUCING THE SAME, COMPOSITION CONTAINING THE SAME AND DYEING PROCESS EMPLOYING THE SAME | KYUNG-IN SYNTHETIC CORPORATION (KR) | 1996-10-24 | — | — | WO | disclosed |
| US-5376151-A | Using iron complexes of azo dyes in place of chromium-based ones | NORTH CAROLINA STATE UNIVERSITY (US) | 1994-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100000032-A1 | PHENOXAZINE DYES | H1-5, IK, PPOX | CDK2 307/4885STAT3 2899/4885CA2 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.